Literature DB >> 20885351

Frequencies of Bcl I, E22E, and N363S of h-GR/NR3C1 restriction fragment length polymorphisms of glucocorticoid receptor gene in Polish adult population.

Tadeusz Pietras1, Michal Panek, Izabela Kuprys-Lipinska, Katarzyna Oszajca, Radoslaw Wujcik, Piotr Kuna, Pawel Gorski, Janusz Szemraj.   

Abstract

BACKGROUND: Polymorphism of the gene encoding the glucocorticoid receptor - h-GR/NR3C1 demonstrates close genetic and biochemical correlation with etiopathogenesis of metabolic, cardiovascular, hematologic, and mental disorders. The natural variability of DNA sequence within the h-GR gene affects both the conformation and the activity of glucocorticoid receptors. Modifications of the amino acid receptor structure give rise to disturbances of the receptor-hormone complex interaction with many genes responsible for normal cellular function. Transactivation, or transrepression, of the genes encoding proteins synthesized within the framework of cellular response to glucocorticosteroids is 1 among many molecular pathways leading to the development of resistance to anti-inflammatory drugs. MATERIAL/
METHODS: A group of 70 healthy participants, with no history of asthma or atopic conditions, qualified for the study. Genotyping was accomplished using PCR-RFLP method.
RESULTS: In healthy, nonatopic population, within the h-GR gene promoter, a polymorphism of Bcl I: GG, GC, and CC occurring with 0.129/0.471/0.40 frequency, were identified. Two polymorphisms were identified in exon 2 at 1220 and 198 position in the h-GR gene: N363S (AA, AG occurring with 0.9/0.1 frequency) and ER22/23EK (GG, GC occurring with 0.843/0.157 frequency).
CONCLUSIONS: The frequency of polymorphisms occurring within the h-GR gene has not been assessed to date in the Polish population. The present study is the first attempt of such estimation. The study is an introduction to more-detailed analysis of the correlation between the occurrence of h-GR gene polymorphisms, and the development of severe, steroid-resistant bronchial asthma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20885351

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  3 in total

1.  The NR3C1 Glucocorticoid Receptor Gene Polymorphisms May Modulate the TGF-beta mRNA Expression in Asthma Patients.

Authors:  Michał Panek; Tadeusz Pietras; Artur Fabijan; Jan Zioło; Łukasz Wieteska; Beata Małachowska; Wojciech Fendler; Janusz Szemraj; Piotr Kuna
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

2.  Cytokine TGFβ Gene Polymorphism in Asthma: TGF-Related SNP Analysis Enhances the Prediction of Disease Diagnosis (A Case-Control Study With Multivariable Data-Mining Model Development).

Authors:  Michał Panek; Konrad Stawiski; Marcin Kaszkowiak; Piotr Kuna
Journal:  Front Immunol       Date:  2022-06-14       Impact factor: 8.786

3.  New insights into the regulation of TGF-β/Smad and MPK signaling pathway gene expressions by nasal allergen and methacholine challenge test in asthma.

Authors:  Michał Gabriel Panek; Michał Seweryn Karbownik; Karol Maksymilian Górski; Marcelina Koćwin; Grzegorz Kardas; Mateusz Marynowski; Piotr Kuna
Journal:  Clin Transl Allergy       Date:  2022-07-02       Impact factor: 5.657

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.